IMMUNOGENICITY OF THE THIRD GENERATION HEPATITIS B VACCINE (pre-S1/pre-S2/S)
Currently, second-generation hepatitis B vaccines are widely used. They are produced in biotechnological eukaryotic yeast-based systems and contain the S-protein domain of HBsAg particle in the complete absence of pre-S1 and pre-S2 domains. At the same time, these antigens were proved to significant...
Guardado en:
Autores principales: | E. V. Esaulenko, A. A. Sukhoruk, K. A. Zakharov, A. A. Yakovlev |
---|---|
Formato: | article |
Lenguaje: | RU |
Publicado: |
Sankt-Peterburg : NIIÈM imeni Pastera
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/30f2051813c64d6ca613589418c60945 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Seroprotection Status of Hepatitis B Vaccine in Children with Type 1 Diabetes Mellitus
por: Dina Elsharkawy, et al.
Publicado: (2021) -
COMPARING HEPATITIS B SEROPROTECTION IN PAKISTANI CHILDREN AT 5 AND 6 YEARS OF AGE AFTER EXPANDED PROGRAMME ON IMMUNIZATION (EPI) VACCINATION
por: Ehsan Qadir, et al.
Publicado: (2020) -
Development of an Inactivated Vaccine against SARS CoV-2
por: Shaikh Terkis Islam Pavel, et al.
Publicado: (2021) -
Immunogenicity of 2-dose pre-exposure rabies vaccine co-administered with quadrivalent influenza vaccine in children
por: Napaporn Chantasrisawad, et al.
Publicado: (2021) -
EFFECTS OF DIFFERENT ADJUVANTS UPON IMMUNOGENICITY OF ANTI-GROUP B STREPTOCOCCAL VACCINE COMPONENTS
por: A. N. Suvorov, et al.
Publicado: (2014)